Skip to content

Drug interactions

Finerenone + Ziprasidone

Severity: Minor

Finerenone and Ziprasidone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Finerenone is metabolised mainly by CYP3A4. Ziprasidone is not a clinically relevant CYP3A4 inhibitor, so a meaningful rise in finerenone exposure is unlikely.

What this interaction means in plain words

Finerenone and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Finerenone belongs to Cardiovascular; Ziprasidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

No established CYP3A4 inhibition by ziprasidone; the interaction is theoretical.

What to do

No dose adjustment is needed. Monitor serum potassium as for routine finerenone therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Finerenone and Ziprasidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Finerenone with Ziprasidone?

MediHelp rates the interaction as minor. Finerenone and Ziprasidone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Finerenone is metabolised mainly by CYP3A4. Ziprasidone is not a clinically relevant CYP3A4 inhibitor, so a meaningful rise in finerenone exposure is unlikely.

How serious is the interaction between Finerenone and Ziprasidone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor serum potassium as for routine finerenone therapy.

What other medicines interact with Ziprasidone?

MediHelp also lists interactions of Ziprasidone with, for example, Amiodarone, Amitriptyline, Arsenic trioxide. The full list is on the Ziprasidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in